|
|
|
|||||
Archive:
| |||||
20, 1998) A National Institute of Allergy and Infectious Diseases (NIAID) grantee in Seattle has found experimental data to support a new hypothesis about the genesis of scleroderma, an autoimmune disorder. (Nov. (Science Daily)
Exhausted B Cells Hamper Immune Response To HIV Jul 15, 2008
Now, researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown that a similar type of exhaustion strikes another important brigade of immune system soldiers: the B cells that make virus-fighting proteins called antibodies. In most HIV-infected individuals not receiving antiretroviral therapy, the virus replicates continuously, causing systemic disturbances that include changes in certain subsets of B cells that... (Science Daily)
BAY AREA BIZ Jul 13, 2008
National Institute of Allergy and Infectious Diseases, United States and Japan Immunosenescence Workshop, Friday through July 21, Hyatt at Fisherman's Wharf. Chemical Producers ibutors Association, annual meeting, next Sunday through July 25, Argonaut Hotel. (San Francisco Chronicle -- Business)
New Hope against the Cold Sore Virus Jul 4, 2008
"This provides a new strategy to use for seeking a cure," said Christopher Beisel, a virologist and program officer at the U.S. National Institute of Allergy and Infectious Diseases, which funded the Duke research. "However, I always caution people that when something like this comes out, and people start talking about cures, that there's a long way to go, starting with animal experiments.". (MEDLINEplus)
Penn animal study identifies new DNA weapon against avian flu Jul 2, 2008
VGX Pharmaceuticals and the National Institute of Allergy and Infectious Diseases provided partial funding for this research. Dr. Weiner sits on the scientific advisory board of VGX, and collaborates with Wyeth, Merck, BMS, Althea, and Virxsys, as well as other companies on DNA vaccine technologies. (EurekAlert!)
The Buzz on Mosquito Protection Jul 1, 2008
Recent reports from the National Institute of Allergy and Infectious Diseases (NIAID) state that widespread appearance of Dengue Fever in the continental United States is a real possibility. The American Mosquito Control Association (AMCA) is an international organization of nearly 2,000 public health professionals dedicated to preserving health through safe, environmentally-sound mosquito control programs since 1935. (Sebastopol Sonoma West Publishing, CA)
Lyme Disease Bacterium Came From Europe Before Ice Age Jun 30, 2008
(June 21, 2001) A new test developed with funding from the National Institute of Allergy and Infectious Diseases (NIAID) has been shown to be highly accurate and sensitive for detecting antibodies to Lyme disease. (June 6, 2000) New research from scientists at the University of Georgia, just published in the journal Science, demonstrates that Borrelia burgdorferi, the bacterium that causes Lyme disease in humans, is the. (Science Daily)
Nintendo Numbing Jun 26, 2008
Besides Bubba, among the 250 headliners: Homeland Security Secretary Michael Chertoff; former Supreme Court Associate Justice Sandra Day O'Connor; Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases; National Endowment for the Arts Chairman Dana Gioia; Austan Goolsbee, economic adviser to soon-to-be-crowned Democratic presidential nominee Sen. Barack Obama; and Douglas Holtz-Eakin, policy adviser to the presumptive Republican presidential pick Sen. (Townhall.com)
Potential Role Of Fish-based Fatty Acids In Resolving, Preventing Asthma Jun 26, 2008
The research, supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, was led by a research team at Brigham and Women's Hospital and Harvard Medical School. Resolvin E1 (RvE1) is a metabolic product of an omega-3 fatty acid found in cold-water fish such as salmon, mackerel and anchovies. (Science Daily)
Exotic illnesses afflict American poor Jun 25, 2008
Dr. Lee Hall, chief of parasitology and international programs at the National Institute of Allergy and Infectious Diseases, said his agency funded research into the diseases, but primarily as global, not national, problems. "Do we need better data? We probably do, but that's probably true . . . for infectious diseases of the poor in general.". (Los Angeles Times)
SeraCare beats odds to rejoin Nasdaq Jun 21, 2008
7 million federal contract with the National Institute of Allergy and Infectious Diseases and sold its genomics unit in Cambridge for $2 million in cash, plus royalties. SeraCare emerged from bankruptcy in May 2007 with the same group of shareholders and a plan to repay its creditors in full. (Boston Globe)
Study: Herpes/HIV Correlation Wrong Jun 21, 2008
The study was paid for by the United States' National Institute of Allergy and Infectious Diseases, other U.S. government institutes, and by GlaxoSmithKline PLC, which sells aciclovir as Zovirax. A small study in Tanzania last year also suggested that treating herpes didn't help reducing HIV susceptibility. (Time.com)
President Bush Honors Presidential Medal of Freedom Recipients Jun 20, 2008
As the Director of the National Institute of Allergy and Infectious Diseases for more than 23 years, Tony Fauci has led the fight against HIV and AIDS. He was also a leading architect and champion of the Emergency Plan for AIDS Relief, which over the past five years has reached millions of people -- preventing HIV infections in infants and easing suffering and bringing dying communities back to life. The man who would lead the fight against this dreaded disease came from an Italian American... (White House News Releases)
Are HIV Prevention Gels Safe For Pregnant Women, Their Babies? Jun 18, 2008
The National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both components of the U.S. National Institutes of Health, are funding the study. Women, who represent nearly half of the 33. (Science Daily)
Ancient Antibody Molecule Offers Clues To How Humans Evolved Allergies Jun 15, 2008
14, 2008) Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered how evolution may have lumbered humans with allergy problems. The team from the Randall Division of Cell & Molecular Biophysics, King's College London are working on a molecule vital to a chicken's immune system which represents the evolutionary ancestor of the human antibodies that cause allergic reactions. (Science Daily)
US fails to get number of AIDS cases below ideal level Jun 13, 2008
Addressing a press conference on Tuesday, Director of the National Institute of Allergy and Infectious Diseases Dr Anthony Fauci said more than 750,000 AIDS cases had been diagnosed and over 500,000 deaths had occurred in the US.. An important aspect of the problem is 40,000 to 52,000 new infections that occurred each year but that level had hit a plateau for the last 14 years, he added. (Daily News & Analysis)
Bush names Presidential Medal of Freedom winners Jun 12, 2008
An adviser to the government on global AIDS issues, he is the director of the National Institute of Allergy and Infectious Diseases. Dr. (Yahoo News -- Politics)
Peter Piot, Head of UN AIDS Agency, to Step Down After 13 Years Jun 11, 2008
Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, also called for more efforts to develop a safe and effective HIV vaccine after the failure of. s product last year, which he called the ``top candidate. (Bloomberg)
Weather, Stomach Bugs And Climate Change: Refining The Model Jun 5, 2008
This work was supported by the U.S. Environmental Protection Agency; the National Institute of Allergy and Infectious Diseases and the National Institute of Environmental Health Sciences, both institutes of the National Institutes of Health. Journal reference. (Science Daily)
Sars patients can provide therapy Jun 4, 2008 AIDS Vaccine, Similar to Merck's Failed Attempt, May Get Human Testing Jun 2, 2008 New Target For Cancer Drugs? Gatekeepers Are Discovered In The Human Cell 'Shredder' May 28, 2008 How Common Vaccine Booster Works May 25, 2008 New Hope For HIV Vaccine: Unique HIV Vaccine Formula Elicits Strong Immune Responses May 24, 2008 Scientists discover how common vaccine booster works May 23, 2008 West Nile Vaccine Breakthrough May 22, 2008 New Latent TB Drug Saves Lives, Money May 20, 2008 AIDS vaccine still out of reach May 18, 2008 Common Bacteria Activating Natural Killer T Cells May Cause Autoimmune Liver Disease May 17, 2008 Most Effective Initial Therapy For HIV-1 Infection Identified May 17, 2008 Class-Sparing Regimens for Initial Treatment of HIV-1 Infection May 15, 2008 Anthrax vaccine to be studied in Seattle May 13, 2008 Bio-Rad, Sandia lab partner on toxin tests May 12, 2008 New Agent Strikes At Most Common Cause Of Infant Hospitalization In U.S. May 8, 2008 Genvec wins third grant from NIH this year May 8, 2008 New agent strikes at respiratory syncytial virus replication May 6, 2008 New Ultrasensitive Assay Detects Most Poisonous Substance Known May 3, 2008 New Vaccine Against Deadly Bird Flu Apr 20, 2008 Air Pollution Affects Respiratory Health In Children With Asthma, Study Shows Apr 18, 2008 Researchers chart how new flu strains travel Apr 17, 2008 Leading HIV researchers to collaborate on vaccine development Apr 16, 2008 Researchers join forces for AIDS vaccine Apr 16, 2008 Boston Trial to Test New HIV/AIDS Vaccine Apr 13, 2008 Nose Spray Anthrax Vaccine Effective In Tests Apr 12, 2008 Cells on path to becoming mature T-cells more flexible than commonly thought Apr 10, 2008 Probable Case of Human-to-Human Bird Flu Transmission Reported Apr 8, 2008 Lingering Bacteria Don't Indicate Chronic Lyme Disease Apr 3, 2008 Genvec wins $600,000 grant Apr 3, 2008 Increasing access to antiretroviral drugs would drastically cut AIDS deaths in South Africa Mar 27, 2008 Government to overhaul AIDS vaccine effort Mar 26, 2008 New Triple-threat Weapon Needed In War Between Man And Microbe Mar 26, 2008 US agency vows to back AIDS study Mar 26, 2008 Mounting evidence shows red wine antioxidant kills cancer Mar 26, 2008 HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun Mar 24, 2008 Lyme Disease Can Be Prevented With New Shot, Study Suggests Mar 21, 2008 Treatment of the Hypereosinophilic Syndrome with Mepolizumab Mar 20, 2008 Cause Of Severe Allergic Reaction To Cancer Drug Found Mar 17, 2008 Nonprofits eligible to win Mosquito Vacuum Mar 8, 2008 UCLA study finds that broccoli may help boost the aging immune system Mar 7, 2008 Anti-HIV Gel Found Safe for Daily Use as Putative Microbicide Feb 29, 2008 Neglected diseases get vaccine research boost Feb 28, 2008 Safer And More Effective Way To Treat Crohn's Disease Feb 23, 2008 Northrop Grumman Showcases Health IT Solutions At HIMSS Annual Conference Feb 21, 2008 Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco Feb 18, 2008 Local flu season may get worse; there's still time to get vaccinated Feb 17, 2008 HIV can 'never be cured' Feb 15, 2008 New Cellular Receptor For HIV Identified Feb 13, 2008 Scientists discover possible key to HIV's attack on people Feb 12, 2008 Sars patients can provide therapy Feb 12, 2008 New mechanism in HIV's cellular attack described Feb 12, 2008 Newly Found HIV Receptor May Offer Therapy Target Feb 12, 2008 Herpes Medication Does Not Reduce Risk Of HIV Infection In Individuals With HSV-2, Study Finds Feb 10, 2008 New Genetic Technology IDs Virus That Killed Transplant Recipients Feb 8, 2008 New Battleground For Viruses And Immune Cells Discovered Feb 7, 2008 Tattooing Best Way to Deliver DNA Vaccines Feb 7, 2008 AIDS Vaccine Research to Be Reaasessed Feb 7, 2008 Genetic-mapping unveiled to test infectious diseases Feb 7, 2008 Scientists confirm new virus responsible for deaths of transplant recipients in Australia Feb 7, 2008 Breastfeeding Now Safer For Infants Of HIV-infected Mothers Feb 6, 2008 Babies Excrete Vaccine-mercury Quicker Than Originally Thought, Study Shows Feb 5, 2008 Novel Vaccine Concept Developed: Could Lead To AIDS Or Cervical Cancer Vaccines Feb 4, 2008 Malaria Vaccine Trials Begin Using 'Chimpanzee Virus' Feb 2, 2008 Anthrax vaccine to be studied in Seattle Feb 2, 2008 Anti-parasite drug may provide new way to attack HIV Feb 1, 2008
A team from the US National Institute of Allergy and Infectious Diseases then tested the most effective of these antibodies in mice and found they prevented the virus from multiplying in the respiratory system. Dr Lanzavecchia said: "At present there is no immunological treatment for Sars, and a vaccine may take several years to produce. "Our approach produces protective antibodies that would provide immediate protection against the Sars virus. (Yahoo News -- SARS)
Protein Plays Key Role In Transmitting Deadly Malaria Parasite To Humans Jun 3, 2008
The study was supported by a grant from the National Institute of Allergy and Infectious Diseases. Other study authors were Dr. Bharath Balu, Jonah Smith and Sarita Mendonca. (Science Daily)
Government advisers voted 23 to 3 on May 30 in favor of the new study, and Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, said he would review their comments and decide ``reasonably soon'' whether to proceed. The government-developed vaccine has components similar to those in a shot made by that was terminated last year when 49 recipients became infected, compared with 33 people who got sham inoculations. (Bloomberg -- US)
20, 2000) Proteins that help clean and organize the inside of certain T cells may assist HIV in spreading through the body, scientists from the National Institute of Allergy and Infectious Diseases (NIAID). (Oct. (Science Daily)
This research was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Journal reference. (Science Daily)
In this phase I clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), volunteers first received three injections of a DNA vaccine which expresses protective antigens from the HIV virus, followed by two injections of a protein vaccine whose components matched those included in the DNA vaccine. The report in Vaccine is the first scientific article in which a DNA prime-protein boost combination vaccination method is tested in humans for HIV vaccine... (Science Daily)
In an online paper in the journal Nature, Yale University researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, explain how a common ingredient in many vaccines stimulates and interacts with the immune system to help provide protection against infectious diseases. According to Eurekalert, the news service of the American Association for the Advancement of Science, vaccines must possess not only the bacterial or viral... (Hindu)
ScienceDaily (May 21, 2008) University of Queensland researchers have made a giant leap forward in the race to develop a vaccine for the potentially debilitating West Nile virus. Associate Professor Alex Khromykh, from UQ's School of Molecular & Microbial Sciences, and colleagues have found a way to generate immune response levels comparable to a live virus vaccine, which could also help suffers of other disease such as dengue fever and Japanese encephalitis. (Science Daily)
The National Institute of Allergy and Infectious Diseases has more about. Copyright. (Health-Finder)
"There are so many things we do not know in this field of HIV vaccines," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said at a summit his organization hosted in March to evaluate the situation going forward following the failure of the Merck vaccine. At the summit, leading AIDS specialists discussed avenues of research that remain largely unexplored, such as protection at the level of the mucous membranes, and the natural immunity of certain species of... (India Times, India -- Health/Science)
The Taconic Emerging Models Program, supported by grants from the Merck genome Research Institute, the National Institute of Allergy and Infectious Diseases and JDRF, made available the mice used in the study. Adapted from materials provided by , via , a service of AAAS.. (Science Daily)
D., and Lynne Peeples, M.S., Harvard School of Public Health; William Powderly, M.D., University College, Dublin, Ireland; Karin Klingman, M.D., National Institute of Allergy and Infectious Diseases, Division of AIDS.; Kevin Garren, Ph ... The study was conducted as part of the AIDS Clinical Trials Group with funding from the National Institute of Allergy and Infectious Diseases. (Science Daily)
From the University of Pittsburgh, Pittsburgh (S.A.R., J.W.M.); the University of California, San Diego, San Diego (R.H.); the Harvard School of Public Health, Boston (A.G.D., L.P.); University College Dublin, Dublin (W.G.P.); the Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD (K.L.K.); Abbott Laboratories, Abbott Park, IL (K.W.G.); Bristol-Myers Squibb, Plainsboro, NJ (T.G.); Gilead Sciences, Foster City, CA (J.F.R.); Social and Scientific Systems, Silver... (New England Journal of Medicine)
The private, non-profit Benaroya Research Institute was awarded one of 14 grants in a $74 million program launched yesterday by the National Institute of Allergy and Infectious Diseases. The project aims to find better vaccines or drugs to protect against infectious diseases such as influenza, West Nile virus or bioterrorism agents such as anthrax. (Yahoo News -- Anthrax)
2 million, five-year grant from the National Institute of Allergy and Infectious Diseases for a biotoxin test they are developing. The goal is to design a small, portable and easy-to-use instrument to detect signs of such toxins in blood. (East Bay Business Times, CA)
This research was conducted under a subcontract to Garofalo from the National Institute of Allergy and Infectious Diseases Viral Respiratory Pathogens Research Unit. Adapted from materials provided by. (Science Daily)
Gaithersburg-based Genvec Inc. (NASDAQ: GNVC) announced Wednesday that it has received a two-year, $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the. This is the third $600,000 NIH grant Genvec has secured in 2008. (Washington Business Journal, DC)
This research was conducted under a subcontract to Garofalo from the National Institute of Allergy and Infectious Diseases Viral Respiratory Pathogens Research Unit. The University of Texas Medical Branch at Galveston Public Affairs Office 301 University Boulevard, Suite 3. (EurekAlert!)
Funding to develop the new assay was provided by the National Institute of Allergy and Infectious Diseases through its biodefense network partner the Pacific South West Regional Center of Excellence. Adapted from materials provided by , via , a service of AAAS.. (Science Daily)
National Institute of Allergy and Infectious Diseases and the CDC's National Center for Infectious Diseases and National Vaccine Program provided funding for the study. The other researchers involved with The Journal of Infectious Diseases study were paper co-lead researcher Mary Hoelscher, postdoctoral researcher Sanjay Garg, research scientists Vic Veguilla and Yumi Matsuoka, and principal investigators Jacqueline Katz and Ruben Donis, all of the CDC; and co-lead researcher Neetu Singh,... (Science Daily)
Using data collected from the National Institute of Allergy and Infectious Diseases (NIAID) Inner-City Asthma Study (ICAS), researchers examined 861 children with persistent asthma, aged 5 to 12 years, living in low-income areas in seven U.S. inner-city communities: Boston, the Bronx, Chicago, Dallas, New York City, Seattle and Tucson ... The study was funded by NIH's National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Environmental Health Sciences (NIEHS), and... (Science Daily)
The group charged with making the decisions about vaccines has been right about 80% of the time, said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, and the new findings should lead to an even higher success rate. "If we have competing candidates, this will help to pick which virus should go in a vaccine," added Dr. Arnold S. Monto, an epidemiologist and flu specialist at the University of Michigan. (Los Angeles Times)
Established in 2005 by the National Institute of Allergy and Infectious Diseases, CHAVI, headquartered at Duke University, is an international consortium of 70 investigators at 37 institutions working to overcome major roadblocks in HIV vaccine development. The International AIDS Vaccine Initiative is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. (EurekAlert! -- Business News)
CHAVI, established in 2005 by the National Institute of Allergy and Infectious Diseases, is based at Duke University, but includes a consortium of 70 investigators at 37 institutions, including UNC-Chapel Hill. Its mission was to bring leading AIDS researchers under a single organization, to share research findings and focus on specific areas of inquiry. (News & Observer)
The rAd26 vaccine was developed by the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) program, sponsored by the U.S. National Institute of Allergy and Infectious Diseases. The program brings together academic and industry researchers to accelerate development of promising HIV/AIDS vaccine candidates. (Health-Finder)
D., acting lab chief at the Laboratory of Bacterial Diseases within the National institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Although first assembled a decade ago, no one had yet looked at whether it would make a good component for a candidate anthrax vaccine. (Science Daily)
This work was supported by grants from the National Institute of Allergy and Infectious Diseases, the Leukemia and Lymphoma Society, and an Institutional Training Grant from the National Cancer Institute. PENN Medicine is a $3. (EurekAlert!)
(SOURCES: Anthony S. Fauci, M.D. director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md ... Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which funded the study, said, "This is not something new. Limited human-to-human transmission has been seen intermittently for years and years. This is just another example among a few. It's what we call a dead-end person-to-person transmission.". (Health-Finder)
Funding for this study was provided by a U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases. Adapted from materials provided by. (Science Daily)
Genvec, which is also working on vaccines to fight cancer, flu and genital herpes, said the money is a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases of NIH. The two-year grant will be used to develop enhancements to Genvec's adenovector technology for vaccine applications against malaria. "In addition to advancing our malaria vaccine program, work under this grant may provide improvements to our technology that could be applied... (Washington Business Journal, DC)
The study was funded by the National Institute of Allergy and Infectious Diseases and the Doris Duke Charitable Foundation. Study co-authors are Mariam Fofana, Nomita Divi, Bingxia Wang, and Kenneth Freedberg of the MGH; Robin Wood, University of Cape Town, South Africa; Milton Weinstein and Sue Goldie, Harvard School of Public Health; Neil Martinson, Johns Hopkins University; Elena Losina, Brigham and Womens Hospital; Yazdan Yazdanpanah, Laboratory of Economic and Social Research, Lille,... (EurekAlert!)
"We need to turn the nob in the direction of discovery. That is unambiguous," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who convened the meeting outside of Washington. advertisement. (MSNBC -- Health)
(Credit: Courtesy of National Institute of Allergy and Infectious Diseases of the NIH). Related Stories. (Science Daily)
"We will not discontinue research, period. Not only will we not decrease it, we will in fact try to increase it," Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said at a summit of top HIV/AIDS researchers in Bethesda. The agency organized the gathering to help scientists regroup after & Co. announced that it had halted tests of a prominent vaccine candidate in September. (Baltimore Sun)
The National Institute of Allergy and Infectious Diseases funded the research through a URMC program called the Center for Medical Countermeasures Against Radiation. Co-authors on the studies are: Weimin Sun, Wei Wang, Jung Kim, Peter Keng, Shanmin Yang, Hengshan Zheng, Chaomei Liu, Lurong Zhang, Jacqueline P. Williams, Steven Swarts and Amy K. Huser. (EurekAlert!)
Co-authored by Dr. Homayoon Khanlou, AHF's Chief of Medicine/U.S. and Michael Weinstein, AHF's President, the op ed, "Enough is Enough," has been published on the eve of the HIV Vaccine Summit assembled by the director of the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Anthony Fauci and scheduled for this upcoming Tuesday, March 25th in Bethesda, Maryland ... Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), recently stated:... (PR Newswire)
21, 2001) A new test developed with funding from the National Institute of Allergy and Infectious Diseases (NIAID) has been shown to be highly accurate and sensitive for detecting antibodies to Lyme disease. . (Science Daily)
From the Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati (M.E.R.); the National Institute of Allergy and Infectious Diseases, Bethesda, MD (A.D.K.); Service de M;decine Interne, H pital Erasme, Universit; Libre de Bruxelles, and the Institute for Medical Immunology, Gosselies, Belgium (F.E.R.); Service de M;decine Interne, H pital Foch, Suresnes, France (J.E.K.); Beth Israel Deaconess Medical Center, Harvard Medical School, Boston (P.F.W.); the University of... (New England Journal of Medicine)
Now researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have discovered that specific pre-existing antibodies cause the severe reaction to the drug. This discovery in turn has enabled them to explain the unusual geographic pattern of this reaction seen among individuals in the United States. (Science Daily)
Eastern Equine Encephalitisand dog heartworm - both spread by mosquitoes - also pose a significant and continued threat this coming year, and recent reports from the National Institute of Allergy and Infectious Diseases state that widespread appearance of dengue fever in the continental U.S. is a real possibility. Stinger Mosquito Vacuums are developed specifically to help reduce both the annoyance of biting mosquitoes and the risk of dangerous mosquito-borne illnesses in a one-acre area using... (Danvers Herald, MA)
The study was funded by the National Institute on Aging, the UCLA Claude D. Pepper Older Adults Independence Center, and the National Institute of Allergy and Infectious Diseases. Other study authors included Berenice Barajas and Dr. Meiying Wang. (EurekAlert!)
Personalize Your Medical News. PUTTING BREAKING MEDICAL NEWS INTO PRACTICE Friday, February 29, 2008. (MedPage Today)
The new institute will be headed by Allan Saul, who led the malaria vaccine programme at the US National Institute of Allergy and Infectious Diseases before moving to Novartis last year. The plan is to develop a polyvalent vaccine (effective against more than one strain) for three forms of Salmonella infection and a polyvalent vaccine for Shigella and ETEC (enterotoxigenic Escherichia coli). (Nature News Service)
15, 2004) In a small, initial clinical trial led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, doctors found that up to 75 percent of people. (Feb. (Science Daily)
The company is also developing an integrated data warehouse and bioinformatics framework for the National Institute of Allergy and Infectious Diseases (NIAID) under the Bioinformatics Integration Support Contract project, and the corresponding system, the Immunology Database and Access Portal. This scientific data management initiative links genomic, basic scientific and clinical data from various sources to enable scientists to contribute, access and exchange complex, high-quality data sets,... (Primezone Releases)
The National Institute of Allergy and Infectious Diseases funded this research. The UCLA AIDS Institute, established in 1992, is a multidisciplinary think-tank drawing on the skills of top-flight researchers in the worldwide fight against HIV and AIDS, the first cases of which were reported in 1981 by UCLA physicians. (EurekAlert!)
However, people can have the virus in their system and not even feel symptoms until up to four days later according to the National Institute of Allergy and Infectious Diseases. And, with winter weather keeping people inside and in closer contact with one another, it is more common to pass germs to family, co-workers, and others. (Lodi News Sentinel, CA)
"It might not ever be possible to completely eradicate the virus from the body, even though people are doing well," says Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, who led the research. He adds, however, that this doesn't mean that patients will be more likely than previously thought to pass on the virus to others. (Nature News Service)
12, 2008) A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). See also. (Science Daily)
The findings were reported online Sunday in the journal Nature Immunology by a team headed by Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases. For years, scientists have known that HIV rapidly invades the lymph nodes and lymph tissues that are abundant throughout the gut, or intestines. (International Herald Tribune)
A team from the US National Institute of Allergy and Infectious Diseases then tested the most effective of these antibodies in mice and found they prevented the virus from multiplying in the respiratory system. Dr Lanzavecchia said: "At present there is no immunological treatment for Sars, and a vaccine may take several years to produce. "Our approach produces protective antibodies that would provide immediate protection against the Sars virus. (Yahoo News -- SARS)
" "They begin to shed light on the mysterious process. why the virus preferentially grows in the gut," Greene said. Fauci, James Arthos, Claudia Cicala, Elena Martinelli and their colleagues showed that a molecule, integrin alpha-4 beta-7, which naturally directs immune cells to the gut, is also a receptor for HIV. A protein on the virus' envelope, or outer shell, sticks to a molecule in the receptor that is linked specifically to the way CD4 cells home in on the gut, the researchers said.... (San Francisco Chronicle)
D., of the National Institute of Allergy and Infectious Diseases, and colleagues. The finding that HIV can use it to speed replication may help explain the early massive destruction of immune cells in the gut-associated lymphoid tissue (GALT), a phenomenon that leads to HIV-induced immune dysfunction, Dr. Arthos and colleagues said online in Nature Immunology. (MedPage Today)
The Phase III clinical trial was led by the University of Washington in Seattle, in coordination with the HIV Prevention Trials Network, an international consortium funded by the National Institute of Allergy and Infectious Diseases (NIAID) in the National Institutes of Health. The findings were presented this week at the Conference on Retroviruses and Opportunistic Infections in Boston. (Science Daily)
"The real story is the coming-of-age of a sophisticated, highly sensitive mass screening type of molecular diagnosis," added Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases. "It can be used not only for such things as this isolated mystery of a cluster of infections but also to search for a microbe in an infection in which one has not been detected.". (MEDLINEplus)
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have added an important dimension to this knowledge. See also. (Science Daily)
The U.S. National Institute of Allergy and Infectious Diseases has more about. Copyright. (Health-Finder)
Scientists were badly shaken, and 15 vaccine researchers wrote to Dr. Tony Fauci, chief of the National Institute of Allergy and Infectious Diseases asking for a reassessment. "When the STEP trial failed, it caused all of us to drop back a few yards," said Fauci in a telephone interview. (MedIndia)
"There is no doubt that this technology is going to play a major role in our defenses," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. The coordinated global response showed "the way it should work" when a new killer bug emerges. (USA Today -- Tech)
"The small pieces of viral genetic material recovered through this powerful high throughput sequencing method were used to design specific tests for detecting the virus in clinical samples and enabling detailed characterization. said Gustavo Palacios, PhD, first author of the paper and assistant professor in the Center for Infection and Immunity at the Mailman School. Surveys at Columbia and the VIRDL revealed that viral RNA was present in a total of 22 out of 30 samples of tissue, blood, or... (EurekAlert!)
The SWEN study was funded by the Division of AIDS at the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health. Nevirapine is manufactured by the German pharmaceutical company Boehringer Ingelheim and sold under the brand name Viramune. (Science Daily)
This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. It was performed in conjunction with investigators Angela Gentile, M.D, Norberto Giglio, M.D., and Veronica Umido, M.D., of R. Gutierrez Children's Hospital in Buenos Aires; Carlos Gotelli, Ph. (Science Daily)
D., and Scott E. Hensley (now at the National Institute of Allergy and Infectious Diseases). Lin is also affiliated with the University of Pennsylvania. (Science Daily)
11, 2003) The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has reached a milestone in its efforts to support accelerated development of malaria. (Jan. (Science Daily)
The private, non-profit Benaroya Research Institute was awarded one of 14 grants in a $74 million program launched yesterday by the National Institute of Allergy and Infectious Diseases. The project aims to find better vaccines or drugs to protect against infectious diseases such as influenza, West Nile virus or bioterrorism agents such as anthrax. (Yahoo News -- Anthrax)
D., head of the Molecular Virology Section at the National Institute of Allergy and Infectious Diseases, with the help of a respected editorial board, and has an impact factor of 4. 32. (EurekAlert!)
Back to Health News
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2008 |